Edex 40 MCG cartridge 2-PK kits
Ended Awarded
- Contract number
- SPE2DB26FJRWY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,812
Award facts
- Contract value 100% obligated
- $1,811.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,811.96 to DMS Pharmaceutical Group Inc. on October 28, 2025, for EDEX 40 MCG cartridge 2-pack kits. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is firm fixed-price in structure with an ultimate completion date of October 29, 2025, and will be performed at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The parent contract authorizes DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support the Department of Defense's military healthcare facilities worldwide, with DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrating its capability to fulfill the specialized pharmaceutical requirements of federal military medical operations.
Quick answers
Who was awarded contract SPE2DB26FJRWY?
SPE2DB26FJRWY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FJRWY worth?
The government has obligated $1,812 on SPE2DB26FJRWY.
Is contract SPE2DB26FJRWY an order under another contract?
Yes. SPE2DB26FJRWY is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWY competed?
The extent of competition for SPE2DB26FJRWY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award